Henry Ji

Dr. Henry H.
Ji is an Executive Chairman, President & CEO at Semnur Pharmaceuticals, Inc., an Executive Chairman, President & CEO at Scilex Holding Co., a Chief Executive Officer & Secretary at Semnur, Inc., a President at BioVintage, Inc., a Chairman, President & Chief Executive Officer at Sorrento Therapeutics, Inc., a Chief Executive Officer at Oqory, Inc. and a Chief Executive Officer & Chief Financial Officer at Scintilla Pharmaceuticals, Inc. He is on the Board of Directors at JP 3E Holdings, Inc., Scilex Pharmaceuticals, Inc. and Elsie Biotechnologies Inc. Dr. Ji was previously employed as an Executive Chairman by Scilex Holding Co., an Executive Chairman by Scilex, Inc., a Secretary & Chief Scientific Officer by Quikbyte Software, Inc., a Director & Chief Scientific Officer by Sorrento Therapeutics, Inc. /Old/, a Vice President by CombiMatrix Corp., a Vice President by Stratagene Corp., a President, Chief Executive Officer & Director by Stratagene Genomics, Inc., and a Managing Director by Hongye SD Group LLC.
He also served on the board at Celularity, Inc. (United States) and NantKwest, Inc. He received his undergraduate degree from Fudan University and a doctorate degree from the University of Minnesota.